Suspended US rider Adam Bergman has admitted using EPO. On April 6, 2004, then-23-year-old Bergman returned a positive result for recombinant human Erythropoietin (rEPO) in an out-of-competition test. He subsequently finished 11th in the Tour de Georgia, before the test result was known, and was subsequently sacked from his team at the time, Jelly Belly.
In July 2004, Bergman accepted a two-year suspension from USADA but did not admit using rEPO. He has now conceded that the test result was correct and he did use the drug, which improves the body's ability to carry oxygen in the blood by stimulating the production of red blood cells, at the risk of death by heart attack because the blood becomes too thick.
Thank you for reading 5 articles in the past 30 days*
Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read any 5 articles for free in each 30-day period, this automatically resets
After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59
Join now for unlimited access
Try your first month for just £1 / $1 / €1
